Cargando…

The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program

In 2008, the NIH launched an undiagnosed diseases program to investigate difficult to diagnose, and typically, multi-system diseases. The objective of this study was to evaluate the presence of psychiatric symptoms or psychiatric diagnoses in a cohort of patients seeking care at the Emory Special Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Waserstein, Gabriella, Partin, Clyde, Cohen, Debra, Schettler, Pamela, Kinkead, Becky, Rapaport, Mark Hyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553712/
https://www.ncbi.nlm.nih.gov/pubmed/31170170
http://dx.doi.org/10.1371/journal.pone.0216937
_version_ 1783424860016345088
author Waserstein, Gabriella
Partin, Clyde
Cohen, Debra
Schettler, Pamela
Kinkead, Becky
Rapaport, Mark Hyman
author_facet Waserstein, Gabriella
Partin, Clyde
Cohen, Debra
Schettler, Pamela
Kinkead, Becky
Rapaport, Mark Hyman
author_sort Waserstein, Gabriella
collection PubMed
description In 2008, the NIH launched an undiagnosed diseases program to investigate difficult to diagnose, and typically, multi-system diseases. The objective of this study was to evaluate the presence of psychiatric symptoms or psychiatric diagnoses in a cohort of patients seeking care at the Emory Special Diagnostic Service clinic. We hypothesized that psychiatric symptoms would be prevalent and associated with trauma exposure, and a decreased quality of life and functioning. This is a cross-sectional, retrospective analysis of 247 patients seen between February 7, 2014 and May 31, 2017. The sources for data included the Emory Health History Questionnaire (HHQ) that had the work and social adjustment and quality of life enjoyment and satisfaction questionnaire–short form (QLSQ) embedded in it; medical records, and the comprehensive standardized special diagnostic clinic forms. Primary outcomes were presence of any psychiatric symptom, based on report of the symptom on the HHQ or medical record, or presence of a confirmed preexisting psychiatric disorder. Seventy-two percent of patients had at least one psychiatric symptom while 24.3% of patients had a pre-existing psychiatric diagnosis. Patients with any psychiatric symptom had significantly diminished Q-LES-Q scores (45.27 ± 18.63) versus patients with no psychiatric symptoms (62.01 ± 21.57, t = 5.60, df = 225, p<0.0001) and they had significantly greater functional disability. Patients with a psychiatric disorder also had significantly diminished Q-LES-Q scores (45.16 ± 17.28) versus those without a psychiatric diagnosis (51.85 ± 21.54, t = 2.11, df = 225, p = 0.036) but did not have significantly increased functional impairment. Both patients with psychiatric symptoms and ones with psychiatric disorders had an increased prevalence of trauma. Psychiatric symptoms are prevalent in patients evaluated for undiagnosed disorders. The presence of any psychiatric symptom, with or without a formal psychiatric diagnosis, significantly decreases quality of life and functioning. This suggests that assessment for psychiatric symptoms should be part of the evaluation of individuals with undiagnosed disorders and may have important diagnostic and treatment implications.
format Online
Article
Text
id pubmed-6553712
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65537122019-06-17 The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program Waserstein, Gabriella Partin, Clyde Cohen, Debra Schettler, Pamela Kinkead, Becky Rapaport, Mark Hyman PLoS One Research Article In 2008, the NIH launched an undiagnosed diseases program to investigate difficult to diagnose, and typically, multi-system diseases. The objective of this study was to evaluate the presence of psychiatric symptoms or psychiatric diagnoses in a cohort of patients seeking care at the Emory Special Diagnostic Service clinic. We hypothesized that psychiatric symptoms would be prevalent and associated with trauma exposure, and a decreased quality of life and functioning. This is a cross-sectional, retrospective analysis of 247 patients seen between February 7, 2014 and May 31, 2017. The sources for data included the Emory Health History Questionnaire (HHQ) that had the work and social adjustment and quality of life enjoyment and satisfaction questionnaire–short form (QLSQ) embedded in it; medical records, and the comprehensive standardized special diagnostic clinic forms. Primary outcomes were presence of any psychiatric symptom, based on report of the symptom on the HHQ or medical record, or presence of a confirmed preexisting psychiatric disorder. Seventy-two percent of patients had at least one psychiatric symptom while 24.3% of patients had a pre-existing psychiatric diagnosis. Patients with any psychiatric symptom had significantly diminished Q-LES-Q scores (45.27 ± 18.63) versus patients with no psychiatric symptoms (62.01 ± 21.57, t = 5.60, df = 225, p<0.0001) and they had significantly greater functional disability. Patients with a psychiatric disorder also had significantly diminished Q-LES-Q scores (45.16 ± 17.28) versus those without a psychiatric diagnosis (51.85 ± 21.54, t = 2.11, df = 225, p = 0.036) but did not have significantly increased functional impairment. Both patients with psychiatric symptoms and ones with psychiatric disorders had an increased prevalence of trauma. Psychiatric symptoms are prevalent in patients evaluated for undiagnosed disorders. The presence of any psychiatric symptom, with or without a formal psychiatric diagnosis, significantly decreases quality of life and functioning. This suggests that assessment for psychiatric symptoms should be part of the evaluation of individuals with undiagnosed disorders and may have important diagnostic and treatment implications. Public Library of Science 2019-06-06 /pmc/articles/PMC6553712/ /pubmed/31170170 http://dx.doi.org/10.1371/journal.pone.0216937 Text en © 2019 Waserstein et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Waserstein, Gabriella
Partin, Clyde
Cohen, Debra
Schettler, Pamela
Kinkead, Becky
Rapaport, Mark Hyman
The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
title The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
title_full The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
title_fullStr The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
title_full_unstemmed The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
title_short The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
title_sort prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553712/
https://www.ncbi.nlm.nih.gov/pubmed/31170170
http://dx.doi.org/10.1371/journal.pone.0216937
work_keys_str_mv AT wasersteingabriella theprevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT partinclyde theprevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT cohendebra theprevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT schettlerpamela theprevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT kinkeadbecky theprevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT rapaportmarkhyman theprevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT wasersteingabriella prevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT partinclyde prevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT cohendebra prevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT schettlerpamela prevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT kinkeadbecky prevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram
AT rapaportmarkhyman prevalenceandimpactofpsychiatricsymptomsinanundiagnoseddiseasesclinicalprogram